Znanstveni rad - Prethodno/kratko priopćenje
MPN-541 Estimated Plasma Volume Status in Patients With Primary Myelofibrosis and Associated Thrombotic and Mortality Risks
Clinical Lymphoma Myeloma and Leukemia, 22 (2022); S341-S342. https://doi.org/10.1016/s2152-2650(22)01467-7

Lucijanić, Marko; Krečak, Ivan; Soric, Ena; Sabljic, Anica; Galušić, Davor; Holik, Hrvoje; Periša, Vlatka; Perić, Martina Morić; Zekanović, Ivan; Kušec, Rajko

Citirajte ovaj rad

Lucijanić, M., Krečak, I., Soric, E., Sabljic, A., Galušić, D., Holik, H. ... Kušec, R. (2022). MPN-541 Estimated Plasma Volume Status in Patients With Primary Myelofibrosis and Associated Thrombotic and Mortality Risks. Clinical Lymphoma Myeloma and Leukemia, 22., S341-S342. doi: 10.1016/s2152-2650(22)01467-7

Lucijanić, Marko, et al. "MPN-541 Estimated Plasma Volume Status in Patients With Primary Myelofibrosis and Associated Thrombotic and Mortality Risks." Clinical Lymphoma Myeloma and Leukemia, vol. 22, 2022, str. S341-S342. https://doi.org/10.1016/s2152-2650(22)01467-7

Lucijanić, Marko, Ivan Krečak, Ena Soric, Anica Sabljic, Davor Galušić, Hrvoje Holik, Vlatka Periša, Martina Morić Perić, Ivan Zekanović i Rajko Kušec. "MPN-541 Estimated Plasma Volume Status in Patients With Primary Myelofibrosis and Associated Thrombotic and Mortality Risks." Clinical Lymphoma Myeloma and Leukemia 22 (2022): S341-S342. https://doi.org/10.1016/s2152-2650(22)01467-7

Lucijanić, M., et al. (2022) 'MPN-541 Estimated Plasma Volume Status in Patients With Primary Myelofibrosis and Associated Thrombotic and Mortality Risks', Clinical Lymphoma Myeloma and Leukemia, 22, str. S341-S342. doi: 10.1016/s2152-2650(22)01467-7

Lucijanić M, Krečak I, Soric E, Sabljic A, Galušić D, Holik H, i sur.. MPN-541 Estimated Plasma Volume Status in Patients With Primary Myelofibrosis and Associated Thrombotic and Mortality Risks. Clinical Lymphoma Myeloma and Leukemia [Internet]. 2022. [pristupljeno 13.07.2024.];22:S341-S342. doi: 10.1016/s2152-2650(22)01467-7

M. Lucijanić, et al., "MPN-541 Estimated Plasma Volume Status in Patients With Primary Myelofibrosis and Associated Thrombotic and Mortality Risks", Clinical Lymphoma Myeloma and Leukemia, vol. 22, str. S341-S342, 2022. [Online]. Dostupno na: https://urn.nsk.hr/urn:nbn:hr:184:111340. [Citirano: 13.07.2024.]

Prijavite se u repozitorij kako biste mogli spremiti objekt u svoju listu.